trending Market Intelligence /marketintelligence/en/news-insights/trending/uTB_dx4np6r5oonuMXuP3g2 content esgSubNav
In This List

Momenta Pharmaceuticals upsizes offering to raise up to $258.7M

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Momenta Pharmaceuticals upsizes offering to raise up to $258.7M

Momenta Pharmaceuticals Inc. priced a common stock offering to raise about $225 million in gross proceeds.

The Cambridge, Mass.-based biotechnology company is selling 14,516,130 common shares at $15.50 apiece. Momenta has also granted underwriters a 30-day option to buy 2,177,419 additional shares for additional proceeds of about $33.7 million.

Goldman Sachs & Co. LLC and J.P. Morgan are joint lead book-running managers, while Stifel is a book-running manager for the offering.